Dyslipidemia prevalence and its relationship with insulin resistance on a population of apparently healthy subjects;Prevalencia de dislipidemias en una población de sujetos en apariencia sanos y su relación con la resistencia a la insulina

Salud Publica de Mexico

Volumn 50, Issue 5, 2008, Pages 375-382

  Munguía Miranda, Catarina ^a,b   Sánchez Barrera, Reyna Gabriela ^a   Hernández Saavedra, Daniel ^a   Cruz López, Miguel ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b NONE   (Mexico)

Author keywords

Dyslipidemia; Insulin resistance; Mexico; Obesity

Indexed keywords

EID: 57349164856     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342008000500010     Document Type: Article

References (26)

1. Kim C, Hofer TP, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model. Gen Intern Med 2003;18(10):854-863.
2. Anderson GF, Chu E. Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med 2007;356(3):209-211.
3. American Heart Association. American Heart Association 2002. Heart and Stroke Stadistical Update. Dallas, Tx: American Heart Association, 2001:1-38.
4. American Heart Association. Heart disease and stroke statistics-2006 update. Dallas, TX: American Heart Association, 2006.
5. Coronary Heart Disease Stadistics. London: British Heart Foundation Database, 1998. Disponible en: http://www.bhf.org.uk.
6. Oláiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2003.
7. Estadísticas de mortalidad en México: muertes registradas en el año 2000. Salud Publica Mex 2002;44(3):266-282.
8. Meaney E, Lara-Esqueda A, Ceballos-Reyes GM, Asbun J, Vela A, Martinez-Marroquin Y, et al. Cardiovascular risk factors in the urban mexican population: the FRIMEX study. Public Health 2007;121(5):378-384.
9. Aguilar-Salinas CA, Olaiz G, Valles V, Torres JM, Gómez- Pérez FJ, Rull JA, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a mexican nationwide survey. J Lipid Res 2001;42(8):1298-1307.
10. The Expert Panel. Third Report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adults Treatment Panel III). Final report. Circulation 2002;106:3143-3421.
11. Gonzalez-Villalpando C, Stern MP, Arredondo-Perez B, Martinez-Diaz S, Haffner S. Undiagnosed hypercholesterolemia: a serious health challenge. The Mexico City Diabetes Study. Arch Med Res 1996;27(1):19-23.
12. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Sánchez-Castillo C, Attie F, et al. Prevalencia e interrelación de enfermedades crónicas no trasmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003;73(1):62-77.
13. Sepúlveda J. Encuesta Nacional de Salud y Nutrición 2006 (ENSANUT 2006). México: Instituto Nacional de Salud Pública, 2006.
14. Stern MP, Knapp JA, Hazuda HP, Haffner SM, Patterson JK, Mitchell BD. Genetic and environmental determinants of type II diabetes in mexican americans. Is there a "descending limb" to the modernization/diabetes relationship? Diabetes Care 1991;14(7):649-654.
15. Nichaman MZ, Garcia G. Obesity in hispanic americans. Diabetes Care 1991;14(7):691-694.
16. Gonzalez C, Stern MP, Gonzalez E, Rivera D, Simon J, Islas S, et al. The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes. Nutr Rev 1999;57(5 Pt 2):S71-S76.
17. Stern MP, Gonzalez C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992;41(4):484-492.
18. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK. Risk factors for cardiovascular mortality in mexican americans and non-hispanic whites. San Antonio Heart Study. Am J Epidemiol 1990;131(3):423-433.
19. Mitchell BD, González-Villalpando C, Arredondo-Pérez B, García MS, Valdez R, Stern MP. Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vasc Biol 1995;15(6):721-725.
20. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334(15):952-957.
21. González-Villalpando C, Stern MP, Valdez R, Mitchell B, Haffner S. Niveles de lípidos en sangre y riesgo aterogénico en una población urbana abierta. Rev Invest Clin 1993;45(2):127-132.
22. González-Villalpando C, Rivera-Martínez D, Cisneros-Castolo M, González-Villalpando ME, Simón J, Williams K, et al. Seven-year incidence and progression of obesity. Characterization of body fat pattern evolution in low-income Mexico City urban population. Arch Med Res 2003;34(4):348-353.
23. Williams K, Stern MP, Gonzalez-Villalpando C. Secular trends in obesity in Mexico City and in San Antonio. Nutr Rev 2004;62(7):S158-S162.
24. Ramirez-Lopez G, Gonzalez-Villalpando C, Salmeron J, Gonzalez-Ortiz M, Valles-Sanchez V. Triglycerides and high-density lipoprotein cholesterol are associated with insulinemia in adolescents. Salud Publica Mex 2006;48(4):293-299.
25. Sen K, Bonita R. Global health status: two steps forward, one step back. Lancet 2000;356(9229):577-582.
26. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-1350.